Acid Suppressive Drugs
Histamine H2 receptor antagonists (H2RAs) suppress gastric acid production by blocking H2 receptors in parietal cells. Studies have shown that proton pump inhibitors (PPIs) are superior to H2RAs as a treatment for acid-related disorders, such as peptic ulcer disease (PUD) and gastroesophageal reflux...
Saved in:
Main Author: | Cheol Min Shin |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean College of Helicobacter and Upper Gastrointestinal Research
2022-06-01
|
Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
Subjects: | |
Online Access: | http://www.helicojournal.org/upload/pdf/kjhugr-2022-0016.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Gastric Acid Suppression Therapy in Erosive Esophagitis: From H2 Receptor Antagonists, Proton Pump Inhibitors, to Potassium-Competitive Acid Blockers
by: Ryan Herardi, et al.
Published: (2025-07-01) -
History and Pharmacological Mechanism of Gastric Acid-suppressive Drugs
by: Dong Han Yeom, et al.
Published: (2023-09-01) -
Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers
by: Jong Kyu Park
Published: (2023-09-01) -
Comparison of Tegoprazan- and Lansoprazole-Based Fourteen-Day Triple Therapies as First-Line Treatments for Eradication
by: Seokin Kang, et al.
Published: (2024-06-01) -
Comprehensive Analysis of Factors Associated With Eradication Therapy
by: Myung Jin Song, et al.
Published: (2024-06-01)